Fat-specific FUS-DDIT3-transgenic mice establish PPARγ inactivation is required to liposarcoma development

Carcinogenesis

Volumn 28, Issue 10, 2007, Pages 2069-2073

  Pérez Mancera, Pedro Antonio ^a   Vicente Dueñas, Carolina ^a   González Herrero, Inés ^a   Sánchez Martín, Manuel ^a   Flores Corral, Teresa ^a   Sánchez García, Isidro ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 16; CONTROLLED STUDY; EMBRYO; FEMALE; FIBROBLAST; GENE FUNCTION; GENE FUSION; GENE INACTIVATION; GENETIC ASSOCIATION; GENETIC SELECTION; IN VITRO STUDY; IN VIVO STUDY; LIPOSARCOMA; MALE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SPECIFICITY; TRANSGENIC MOUSE; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 2; FIBROBLASTS; HUMANS; LIPOSARCOMA; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, NUDE; MICE, TRANSGENIC; PPAR GAMMA; PROMOTER REGIONS (GENETICS); RNA; RNA-BINDING PROTEIN FUS; TRANSCRIPTION FACTOR CHOP; TRANSLOCATION, GENETIC;

EID: 35148863997     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm107     Document Type: Article

References (23)

1. Ron,D. et al. (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev., 6, 439-453.
2. Crozat,A. et al. (1993) Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature, 363, 640-644.
3. Rabbitts,T.H. et al. (1993) Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcoma. Nat. Genet., 4, 175-180.
4. Knight,J.C. et al. (1995) Translocation t(12;l6)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: Molecular and cytogenetic analysis. Cancer Res., 55, 24-27.
5. Aman,P. et al. (2005) Fusion oncogenes. Semin. Cancer Biol., 15, 159-161.
6. Sánchez-García,I. et al. (1997) Consequences of chromosomal abnormalities in tumour development. Annu. Rev. Genet., 31, 429-453.
7. Perez-Mancera,P.A. et al. (2005) Understanding mesenchymal cancer: the liposarcoma-associated FUS-DDIT3 fusion gene as a model. Semin. Cancer Biol., 15, 206-214.
8. Perez-Caro,M. et al. (2006) Killing time for cancer stem cells (CSC): Discovery and development of selective CSC inhibitors. Curr. Med. Chem., 13, 1719-1725.
9. Pérez-Losada,J. et al. (2000) The chimeric FUS/TLS-CHOP fusion protein specifically induces liposarcomas in transgenic mice. Oncogene, 19, 2413-2422.
10. Zinszner,H. et al. (1994) A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Genes Dev., 8, 2513-2526.
11. Riggi,N. et al. (2006) Expression of the FUS-DDIT3 fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma. Cancer Res., 66, 7016-7023.
12. Pérez-Losada,J. et al. (2000) Liposarcoma initiated by FUS/ TLS-CHOP: The FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma. Oncogene, 19, 6015-6022.
13. Perez-Mancera,P.A. et al. (2002) Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice. Oncogene 21, 1679-1684.
14. Thelin-Jarnum,S. et al. (1999) Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas. Int. J. Cancer, 83, 30-33.
15. Engstrom,K. et al. (2006) The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells. Am. J. Pathol., 168 1642-1653.
16. Kuroda,M. et al. (1997) Oncogenic: Transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-DDIT3 type II chimeric protein. Am. J. Pathol., 151, 735-744.
17. Spiegelman,B.M. et al. (1998) PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor. Diabetes, 47, 507-514.
18. Ailhaud,G. et al. (1992) Cellular and molecular aspects of adipose tissue development. Annu. Rev. Nutr., 12, 207-233.
19. Tanaka,T. et al. (1997) Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J., 16 7432-7443.
20. He,W. et al. (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl Acad. Sci. USA, 100, 15712-15717.
21. Garcia-Hernandez,B. et al. (1997) Murine hematopoietic reconstitution after tagging and selection of retrovirally transduced bone marrow cells. Proc. Natl Acad. Sci. USA, 94, 13239-13244.
22. Wasserman,F. (1965) The development of adipose tissue. In Renold,A. and Cahill,G. (eds) Handbook of Physiology, Vol. 5, American Physiological Society, Washington, DC, 87-100.
23. Cinti,S. et al. (2000) Anatomy of the adipose organ. Eat. Weight Disord., 5, 132-142.